T


Journal

Science translational medicine
ISSN: 1946-6242
Titre abrégé: Sci Transl Med
Pays: United States
ID NLM: 101505086

Informations de publication

Date de publication:
05 04 2023
Historique:
medline: 7 4 2023
entrez: 5 4 2023
pubmed: 6 4 2023
Statut: ppublish

Résumé

Patients who receive chimeric antigen receptor (CAR)-T cells that are enriched in memory T cells exhibit better disease control as a result of increased expansion and persistence of the CAR-T cells. Human memory T cells include stem-like CD8

Identifiants

pubmed: 37018415
doi: 10.1126/scitranslmed.abk1900
doi:

Substances chimiques

Cytokines 0
Receptors, Antigen, T-Cell 0

Banques de données

ClinicalTrials.gov
['NCT03851146']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

eabk1900

Auteurs

Deborah Meyran (D)

Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne 3000, Australia.
Université de Paris, Inserm, U976 HIPI Unit, Institut de Recherche Saint-Louis, Paris F-75010, France.
Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne 3010, Australia.

Joe Jiang Zhu (JJ)

Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne 3000, Australia.
Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne 3010, Australia.

Jeanne Butler (J)

Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne 3000, Australia.

Daniela Tantalo (D)

Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne 3000, Australia.

Sean MacDonald (S)

Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne 3000, Australia.

Thu Ngoc Nguyen (TN)

Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne 3000, Australia.

Minyu Wang (M)

Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne 3000, Australia.
Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne 3010, Australia.

Niko Thio (N)

Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne 3000, Australia.

Criselle D'Souza (C)

Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne 3000, Australia.
Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne 3010, Australia.

Vicky Mengfei Qin (VM)

Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne 3000, Australia.
Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne 3010, Australia.

Clare Slaney (C)

Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne 3000, Australia.
Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne 3010, Australia.

Aaron Harrison (A)

Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne 3000, Australia.

Kevin Sek (K)

Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne 3000, Australia.
Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne 3010, Australia.

Pasquale Petrone (P)

Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne 3000, Australia.

Kevin Thia (K)

Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne 3000, Australia.

Lauren Giuffrida (L)

Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne 3000, Australia.

Andrew M Scott (AM)

Tumor Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Austin Health, Heidelberg, VIC 3084, Australia.
School of Cancer Medicine, La Trobe University, Melbourne, VIC 3086, Australia.

Rachael L Terry (RL)

Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney, NSW 1466, Australia.

Ben Tran (B)

Division of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.

Jayesh Desai (J)

Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne 3010, Australia.
Division of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.

H Miles Prince (HM)

Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne 3000, Australia.
Division of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.

Simon J Harrison (SJ)

Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne 3010, Australia.
Division of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.

Paul A Beavis (PA)

Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne 3000, Australia.
Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne 3010, Australia.

Michael H Kershaw (MH)

Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne 3000, Australia.
Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne 3010, Australia.

Ben Solomon (B)

Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne 3000, Australia.
Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne 3010, Australia.
Division of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.

Paul G Ekert (PG)

Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne 3010, Australia.
Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney, NSW 1466, Australia.
School of Women's and Children's Health, UNSW Sydney, Sydney, NSW 1466, Australia.
Kids Cancer Centre, Sydney Children's Hospital, Randwick, NSW 2031, Australia.
Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, VIC 3052, Australia.

Joseph A Trapani (JA)

Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne 3000, Australia.
Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne 3010, Australia.

Phillip K Darcy (PK)

Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne 3000, Australia.
Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne 3010, Australia.

Paul J Neeson (PJ)

Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne 3000, Australia.
Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne 3010, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH